These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Reduced Nhe1 (Na Liu CL; Liu X; Wang Y; Deng Z; Liu T; Sukhova GK; Wojtkiewicz GR; Tang R; Zhang JY; Achilefu S; Nahrendorf M; Libby P; Wang X; Shi GP Hypertension; 2020 Jul; 76(1):87-100. PubMed ID: 32475310 [TBL] [Abstract][Full Text] [Related]
49. PARP-1 (Poly[ADP-Ribose] Polymerase 1) Inhibition Protects From Ang II (Angiotensin II)-Induced Abdominal Aortic Aneurysm in Mice. Liang ES; Bai WW; Wang H; Zhang JN; Zhang F; Ma Y; Jiang F; Yin M; Zhang MX; Chen XM; Qin WD Hypertension; 2018 Nov; 72(5):1189-1199. PubMed ID: 30354818 [TBL] [Abstract][Full Text] [Related]
50. Knockdown of lncRNA Zhang Z; Zou G; Chen X; Lu W; Liu J; Zhai S; Qiao G Mol Cells; 2019 Mar; 42(3):218-227. PubMed ID: 30726659 [TBL] [Abstract][Full Text] [Related]
51. IKK Epsilon Deficiency Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice by Inhibiting Inflammation, Oxidative Stress, and Apoptosis. Chai H; Tao Z; Qi Y; Qi H; Chen W; Xu Y; Zhang L; Chen H; Chen X Oxid Med Cell Longev; 2020; 2020():3602824. PubMed ID: 32064021 [TBL] [Abstract][Full Text] [Related]
52. Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Thomas M; Gavrila D; McCormick ML; Miller FJ; Daugherty A; Cassis LA; Dellsperger KC; Weintraub NL Circulation; 2006 Aug; 114(5):404-413. PubMed ID: 16864727 [TBL] [Abstract][Full Text] [Related]
54. Amelioration of salvianolic acid C on aortic structure in apolipoprotein E-deficient mice treated with angiotension II. Wu P; Han N; Yu H; Wang L; Li X; Dong Z; Fu W; Yorinaka H; Cho K; Wu W; Liu X; Yang M; Guo DA; Yin J; Jiang B Life Sci; 2016 Dec; 166():75-81. PubMed ID: 27663582 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of development of abdominal aortic aneurysm by glycolysis restriction. Tsuruda T; Hatakeyama K; Nagamachi S; Sekita Y; Sakamoto S; Endo GJ; Nishimura M; Matsuyama M; Yoshimura K; Sato Y; Onitsuka T; Imamura T; Asada Y; Kitamura K Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1410-7. PubMed ID: 22499992 [TBL] [Abstract][Full Text] [Related]
56. In vivo serial assessment of aortic aneurysm formation in apolipoprotein E-deficient mice via MRI. Turner GH; Olzinski AR; Bernard RE; Aravindhan K; Karr HW; Mirabile RC; Willette RN; Gough PJ; Jucker BM Circ Cardiovasc Imaging; 2008 Nov; 1(3):220-6. PubMed ID: 19808546 [TBL] [Abstract][Full Text] [Related]
57. Everolimus limits aortic aneurysm in the apolipoprotein E-deficient mouse by downregulating C-C chemokine receptor 2 positive monocytes. Moran CS; Jose RJ; Moxon JV; Roomberg A; Norman PE; Rush C; Körner H; Golledge J Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):814-21. PubMed ID: 23393391 [TBL] [Abstract][Full Text] [Related]
58. Angiotensin-Converting Enzyme 2 Inhibits Angiotensin II-Induced Abdominal Aortic Aneurysms in Mice. Hao Q; Dong X; Chen X; Yan F; Wang X; Shi H; Dong B Hum Gene Ther; 2018 Dec; 29(12):1387-1395. PubMed ID: 28142259 [TBL] [Abstract][Full Text] [Related]
59. Tryptophan-Derived 3-Hydroxyanthranilic Acid Contributes to Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice In Vivo. Wang Q; Ding Y; Song P; Zhu H; Okon I; Ding YN; Chen HZ; Liu DP; Zou MH Circulation; 2017 Dec; 136(23):2271-2283. PubMed ID: 28978552 [TBL] [Abstract][Full Text] [Related]
60. Effectiveness of cyclooxygenase-2 inhibition in limiting abdominal aortic aneurysm progression in mice correlates with a differentiated smooth muscle cell phenotype. Mukherjee K; Gitlin JM; Loftin CD J Cardiovasc Pharmacol; 2012 Dec; 60(6):520-9. PubMed ID: 22967986 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]